SKYE BIOSCIENCE INC

SKYE · NASDAQ

Updated at 2026-10-13 15:30:43

$1.56-1.26%
Today's High
$1.66
Today’s Low
$1.54
SKYE BIOSCIENCE INC (SKYE) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$1.67
Previous Close
$1.58
Volume
42.4K
Market Cap
$6.99M
P/E Ratio
--
EPS
$-7.92

Previous Day Range

$1.55$1.70

52-Week Range

$1.50$14.08

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
11250 EL CAMINO REAL, SAN DIEGO, CA, UNITED STATES, 92130
Country
US
Listing Date
2014-02-24
Fiscal Year End
December
Shares Outstanding
35.14M
CIK
0001516551

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapeutic drugs that modulate the endocannabinoid system. The company is headquartered in San Diego, California.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

2025-09-30

$0

Operating Expenses

2026-06-30

$11.06M

2026-03-31

$12.5M

2025-12-31

$14.89M

2025-09-30

$13.26M

Net Income

2026-06-30

-$10.78M

2026-03-31

-$12.5M

2025-12-31

-$14.44M

2025-09-30

-$12.75M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

Earnings Per Share

2026-06-30

$-0.27

2026-03-31

$-0.32

2025-12-31

$-2.94

2025-09-30

$-0.32

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$10.62M

2026-03-31

-$12.33M

2025-12-31

-$14.26M

2025-09-30

-$12.57M

Effective Tax Rate

2026-06-30

-0.03%

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.